Corbus Pharmaceuticals Holdings Inc (FRA:3371)
€ 7.9 -0.60 (-7.06%) Market Cap: 159.39 Mil Enterprise Value: 60.94 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 35/100

Corbus Pharmaceuticals Holdings Inc Annual Shareholders Meeting Transcript

May 13, 2026 / 01:00PM GMT
Release Date Price: €9.44 (+3.96%)
Operator

Welcome to the Annual Meeting for Corbus Pharmaceuticals Holdings, Inc. Our host for today's call is Rachelle Jacques, Chair of the Board of Directors.

I will now turn the call over to your host. Ms. Jacques, you may begin.

Rachelle Jacques
Corbus Pharmaceuticals Holdings Inc - Independent Chairman of the Board

Thank you. Good morning. I'm Rochelle Jacques, Chair of the Board of Directors of Corbus Pharmaceuticals Holdings, Inc. I'd like to welcome each of you to our Annual Meeting of Stockholders being held this year by remote communication.

Before I begin the formal portion of this meeting, I would like to take the opportunity to introduce our representatives in attendance today.

[Jean Capello], who will act as the independent Inspector of Elections. Dr. Yuval Cohen, our Chief Executive Officer; Sean Moran, our Chief Financial Officer; and Meghan Houghton, our Vice President of Finance.

Stephen Zapp and Amanda Pappas from Lowenstein Sandler, LLP are outside corporate and securities council, and Mark Fogarty from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot